Jonathan W. Friedberg | Community Health

Jonathan W. Friedberg is a renowned American hematologist and medical researcher, currently serving as the Samuel Durand Professor of Medicine and Director of the James P. Wilmot Cancer Institute at the University of Rochester. With a career spanning over two decades, Friedberg has made significant contributions to the field of hematological malignancies, particularly in the treatment of lymphoma and chronic lymphocytic leukemia. His work has been widely published in prestigious medical journals, including the New England Journal of Medicine and the Journal of Clinical Oncology. Friedberg's research focuses on developing innovative therapies, such as immunotherapy and targeted therapy, to improve patient outcomes. He has received numerous awards for his contributions to medical research, including the National Cancer Institute's Physician-Scientist Award. As a leading expert in his field, Friedberg continues to shape the future of cancer treatment and research, with his work having a profound impact on the lives of patients and families affected by hematological cancers.